Trial intelligence / Profile preview

SPSP and TTP Blocks for Postoperative Analgesia After CABG

NCT07658521Completed

Sponsor
Ain Shams University
Start
Jul 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Accumulated opioid consumption at 48 hours. Started Jul 2026; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07658521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07658521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call